retrospective study
toxicity
associated with
protocol
lomustine
CCNU
cyclophosphamide
CTX
dogs
lymphoma
CCNU
administered
PO
targeted dosage
body
day
CTX
administered
PO
targeted dosage
days
dogs
prophylactic antibiotics
treatments
dogs
study
Neutropenia
principal toxic effect
frequency
grade 4 neutropenia
treatment
CCNU/CTX
confidence interval
mean body weight
dogs
grade 4 neutropenia
mean body weight
dogs
grade 4 neutropenia
dog
hematologic
hepatotoxicity
dogs
evidence
renal
toxicity
hemorrhagic cystitis
Adverse gastrointestinal effects
findings
dose
CCNU
CTX
days
tolerable
tumor-bearing dogs
